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Abstract We have previously reported that glutamate can 
trigger a succession of necrosis and apoptosis in cerebellar 
granule cells (CGC). Since specific blockers of the N-methyl-a- 
aspartate (NMDA) receptor channel prevented both types of cell 
death, the role of Ca2+-dependent processes in the initiation of 
glutamate toxicity was further investigated. We examined the 
possible involvement of mitochondria and the role of the Ca2÷/ 
calmodulin-regulated protein phosphatase, calcineurin, in the 
development of either type of cell death. Cyclosporin A and the 
more selective calcineurin inhibitor, FK-506, prevented the 
development of both early necrosis and delayed apoptosis. In 
addition, cyclosporin A prevented the collapse of mitochondrial 
membrane potential observed during the exposure to glutamate 
and the concomitant necrotic phase. When CsA was added 
immediately after glutamate removal, it also prevented delayed 
apoptosis of neurons that bad survived the necrotic phase. 
Altogether, these results suggest the involvement of calcineurin 
and a role for mitochondrial decnergization as early signals in 
neuronal apoptosis induced by glutamate. 
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1. Introduction 
Evidence from both in vitro and in vivo studies has sug- 
gested a role for the excitatory amino acid, glutamate, in 
several neurologic disorders ranging from acute insults, such 
as stroke, hypoglycemia and epilepsy, to chronic degenerative 
states, such as Huntington's disease and the AIDS dementia 
complex [1]. Overstimulation of glutamate receptors leads to 
sustained Ca 2+ influx, predominantly through the NMDA 
receptor subtype. The resulting intracellular Ca 2+ overload 
activates Ca2+-mediated downstream echanisms and even- 
tually neuronal death [2]. The type of cell death in glutamate- 
treated neurons has been studied both in primary cultures in 
vitro [3-5] and in ischemia models in vivo [6-9], and it has 
been demonstrated that both necrosis and apoptosis take 
place. Necrosis leads to rapid destruction of neurons asso- 
ciated with cellular and organelle swelling, energy depletion 
and membrane destruction. Apoptosis, on the other hand, is 
an active cellular process characterized by chromatin conden- 
sation, DNA fragmentation and the formation of 'apoptotic 
bodies' [10-12]. The degree of apoptosis occurring in vivo is 
frequently underestimated, since secondary necrosis and phag- 
ocytosis of apoptotic ells take place [13]. However, an apop- 
totic component of cell death in the ischemic brain has been 
suggested by experiments showing DNA fragmentation i  the 
ischemic tissue [6-9]. We have recently shown that both ne- 
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crosis and apoptosis occur in cerebellar granule cells (CGCs) 
treated with glutamate [5]. Many neurons died rapidly by 
necrosis during and shortly after the glutamate insult. The 
surviving population later underwent chromatin condensation 
and DNA fragmentation, which are typical of apoptosis. Both 
types of cell death were abolished in the presence of the 
NMDA receptor antagonist, MK-801. In the same study, 
we demonstrated that mitochondria play an important role 
in glutamate-induced neuronal death [5]. During glutamate 
exposure (30 min), we detected a rapid loss of the mitochon- 
drial membrane potential in the entire cell population. In 
more sensitive neurons, massive collapse of membrane poten- 
tial was associated with energy depletion and necrosis, in 
other neurons that, at least in part, retained membrane po- 
tential, apoptosis progressed. 
Mitochondria can actively transport Ca 2+ into the matrix 
via a uniporter driven by the electrochemical proton gradient 
[14]. Ca 2+ accumulation i the mitochondrial matrix leads to 
inner membrane permeability transition. The permeability 
transition is characterized by mitochondrial swelling, loss of 
membrane potential and unspecific release of ions and small 
molecules, including proteins, through a proteinaceous pore 
[15,16]. Therefore, we decided to investigate whether the ob- 
served disturbance of the mitochondrial membrane potential 
during excitotoxicity was associated with mitochondrial per- 
meability transition. For these studies we used cyclosporin A
(CsA), which prevents the opening of the proteinaceous pore 
[17-19]. However, cyclosporin A, in complex with the immu- 
nophilin, cyclophilin, is also a potent inhibitor of the Ca2+/ 
calmodulin-regulated protein phosphatase, calcineurin [20]. 
Calcineurin has a high affinity for Ca 2+ and a broad substrate 
specificity [21]. Thus, we also investigated the effects of FK- 
506, a more selective calcineurin inhibitor, which protects 
against necrosis in cortical cultures [22] and in cultures of 
CGCs [23] by mechanisms different from those sensitive to 
CsA. 
2. Materials and methods 
2.1. Chemicals 
Cyclosporin A was from Biomol Feinchemikalien (Hamburg). FK- 
506 was obtained from Fujisawa Pharmaceuticals. Okadaic acid, N G- 
nitro-L-arginine, propidium iodide and 3-(4,5-dimethylthiazol-2-yl)- 
2,5-diphenyltetrazolium bromide (MTT) were from Sigma (St. Louis, 
MO), whereas 5,5',6,6'-tetrachloro-l,l',3,Y-tetraethylbenzimidazol- 
carbocyanine iodide (JC-1) was from Molecular Probes (Eugene, 
OR). All other chemicals were of the highest available grade of purity 
and obtained from local suppliers. 
2.2. Cell cultures and treatments 
CGCs were isolated from 7 day old rats and cultured as previously 
described [24]. Briefly, CGC (0.25×106 cells/cm 2) were cultured 
in BME medium (Gibco) supplemented with 10% fetal calf serum, 
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25 mM KCI and 0.5% (v/v) penicillin/streptomycin. To prevent he 
growth of glial cells, cytosine arabinoside (10 M) was added 48 h after 
seeding. CGC were used after 8-9 days in culture and were exposed to 
glutamate in a Locke solution (134 mM NaC1, 25 mM KCI, 4 mM 
NaHCO3, 5 mM HEPES, 2.3 mM CaC12, 5 mM glucose) for 30 min. 
Thereafter, cells were reincubated in the culture medium. Inhibitors 
were present 15 min before, during, and 1 h after exposure, added at 
the end of the exposure to glutamate, or added 1 h after the exposure 
to glutamate (see figure legends for details). 
2.3. Cell viability 
Our previous findings [5] have shown that loss of MTT metaboliz- 
ing activity [25] correlates with rapid neuronal lysis during exposure of 
CGCs to glutamate. Thus the MTT assay could be used here as an 
indicator of neuronal cell death by necrosis. 
2.4. Detection of apoptotic ells' 
Cells were fixed in methanol and stained with propidium iodide as 
described in [5]. The cells were imaged and scored under a BioRad 
MRC 600 confocal microscope, using the 488 nm excitation wave- 
length of a krypton/argon laser. 
2.5. Measurements of mitochondrial membrane potential 
In living cells 5,5',6,6'-tetrachloro-l,l',3,3'-tetraethylbenzimidazol- 
carbocyanine iodide (JC-1) exists either as a green fluorescent mono- 
mer (emission: 527 nm) at depolarized mitochondrial membrane po- 
tentials or as an orange-red fluorescent J-aggregate (emission: 590 
nm) at hyperpolarized membrane potentials (negative to -140 mV) 
[26]. JC-1 undergoes a reversible shift in emission as more J-aggre- 
gates form with increasingly negative mitochondrial membrane poten- 
tial. Neurons cultured on glass coverslips were loaded with JC-1 (1.0 
/.tg/ml) for 20 min at 37°C in culture medium containing 2% fetal 
bovine serum. Cells were perfused with a Locke solution and exposed 
to glutamate or the other treatment under a BioRad MRC 600 con- 
focal microscope. Confocal dual emission images were collected as 
described in detail elsewhere [5]. 
3. Results 
As shown in Fig. 1, CsA (100 nM) protected CGCs from 
both necrosis and apoptosis. CsA prevented neuronal necrosis 
when added before, but not after the exposure to glutamate. 
This is in agreement with our previous observation that ne- 
crosis develops during and immediately after the exposure to 
glutamate [5]. In contrast, CsA protected from apoptosis also 
when the addition was performed immediately after the ex- 
posure to glutamate (Fig. 1). CsA was ineffective, if added 1 h 
after glutamate removal. The presence of CsA during gluta- 
mate exposure protected cells from loss of mitochondrial 
membrane potential (Fig. 2) as detected by confocal micros- 
copy using the fluorescent indicator JC-1. 
CsA is also an inhibitor of calcineurin activity, hence its 
effects on glutamate-induced neuronal death may not have 
been solely related to a decreased transition pore permeability. 
To determine the possible involvement of calcineurin in glu- 
tamate-induced necrosis and apoptosis we used a more selec- 
tive calcineurin inhibitor, FK-506. FK-506 (100 riM) pro- 
tected CGCs from both necrosis and apoptosis (Fig. 3), 
whereas okadaic acid, a generic inhibitor of protein phospha- 
tases 1 and 2A (but not of calcineurin), had no effect on cell 
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Fig. 1. Cerebellar granule cells treated with 100 ~M glutamate (glu) 
in the presence or absence of 100 nM cyclosporin A (CsA). Necrosis 
was estimated by the impairment of MTT metabolism and expressed 
as a percentage. In this system, loss of MTT metabolism correlates 
with the rapid loss of membrane integrity, swelling and release of 
intracellular debris typical of necrosis [5]. Results are the 
mean + S.D. (n = 3-5). Apoptosis was estimated by counting neurons 
with condensed apoptotic nuclei. Results are the mean+S.D. 
(n = 3). Inhibitors were present before, during and 1 h after exposure 
to glutamate (A), added directly after glutamate xposure (B) or 
added 1 h after glutamate xposure (C). 
death (results not shown). Neuronal nitric oxide synthase 
(NOS), thought to mediate, at least in part, glutamate toxic- 
ity, is a substrate for calcineurin [22]. Calcineurin-mediated 
dephosphorylation of NOS leads to increased formation of 
nitric oxide (NO). However, in this system, endogenous NO 
generation was not apparently involved in cell death, since 
NOS inhibitors such as N~-nitro-L-arginine (10 ~tM or 100 
ktM) did not protect CGC from the decrease in MTT  metab- 
olism associated with neuronal death (Table 1). 
4. Discussion 
Excessive stimulation of glutamate receptors leads to intra- 
cellular Ca 2+ overload and cell death [2]. We recently demon- 
strated that the type of cell death in CGC cultures exposed to 
glutamate depends on mitochondrial function [5]. Here, we 
report that the presence of cyclosporin A or FK-506 during 
exposure to glutamate protected CGCs from both necrosis 
and apoptosis, suggesting a role for calcineurin in this system, 
in addition to mitochondrial signals. Calcineurin is a Ca2+/ 
calmodulin-regulated protein phosphatase with broad sub- 
strate specificity. Calcineurin substrates that could affect neu- 
ronal survival include NOS [22], transcription factors [27,28] 
and the NMDA receptor itself [29-33]. In this system, the lack 
of a protective ffect of NC-nitro-L-arginine rules out the in- 
volvement of endogenous NO production. Furthermore, 
neither CsA nor FK-506 had any apparent effect on the 
Ca 2+ overload induced by glutamate (data not shown). This 
suggests that calcineurin substrates other than NOS or the 
NMDA receptor channel are involved here. 
CsA is a high-affinity inhibitor of a pore in the matrix- 
delimiting mitochondrial membrane [15,34]. Pore opening or 
Table 1 
Cerebellar granule cells treated with 100 taM glutamate (glu) in the presence or absence of NG-nitro-L-arginine (NA) or treated only with NA 
100 I.tM glu glu+10 ~tM NA glu+100 ~tM NA 10 p_M NA 100 I.tM NA 
MTT metabolism (% of control) 76+2.9 70+ 12 74+2.5 126+ 15 110+ 12 
NA was present 15 min before, during and up to 24 h after exposure. Cell viability was estimated as described in Figs. 1 and 3. Results are mean 
values + S.D. (n -- 3). 
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Fig. 2. Mitochondrial membrane potential in cells loaded with the fluorescent probe JC-1 (see Section 2) and exposed to 1 mM glutamate (glu) 
in the presence or absence of 500 nM cyclosporin A (CsA). Panel a: control 0 min. Panel b: control 30 min. Panel c: glu 0 min. Panel d: glu 
30 min. Panel e: glu+CsA 0 min. Panel f: glu+CsA after 30 min. 
permanence of the pore in an open state is favored by Ca 2+ or 
depolarization. Thus, Ca 2+ overload would allow permeability 
transition with the loss of matrix components. We found that 
in addition to inhibiting calcineurin, CsA protected from the 
loss of mitochondrial membrane potential during exposure to 
glutamate. Thus, CsA could either favor the conservation of
the membrane potential and energy production per se or pre- 
vent the release of a mitochondrial-associated protein with a 
regulatory role in cell death. The first mechanism would be 
relevant for both necrosis and apoptosis. Nevertheless, cells 
surviving the initial necrosis caused by glutamate, which then 
undergo apoptosis, recovered mitochondrial membrane poten- 
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Fig. 3. CGCs treated with 100 ~tM glutamate (glu) in the presence 
or absence of 100 nM FK-506. Necrosis and apoptosis were esti- 
mated as described in the legend to Fig. 1. Results are the 
mean _+ S.D. (n = 3 5) for necrosis and (n = 3) for apoptosis. FK-506 
was added before the exposure to glutamate. 
tial and energy charge also in the absence of CsA [5]. The 
second mechanism which is suggested by previous observa- 
tions [35,36], would be relevant for the development of apop- 
tosis. The findings that CsA prevented apoptosis when added 
immediately after exposure to glutamate, but not 1 h later, 
suggests that an irreversible vent necessary for the progres- 
sion of apoptosis occurs during this time. This may involve 
the release of a mitochondrial 'death factor' [36] from par- 
tially deenergized mitochondria. CsA positive effect on the 
mitochondrial membrane potential is in line with this assump- 
tion, although CsA and possibly FK-506 may in fact prevent 
upstream events involved in mitochondrial deenergization. At
present we cannot distinguish between these two possibilities. 
In conclusion, our results suggest hat calcineurin activity 
and possibly the mitochondrial permeability transition are 
involved in the early phase of neuronal apoptosis elicited by 
glutamate. The possibility that calcineurin and a mitochon- 
drial 'death factor' may interact on the pathway to neuronal 
demise by excitotoxins i under current investigation. 
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